Position in GNLX
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$5,123,582
-$3,303,037 QoQ
Shares Held
2,117,183
+9.5% QoQ
Ownership
4.72%
of shares outstanding
% of Portfolio
2.81%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GNLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WOODWARD DIVERSIFIED CAPITAL, LLC holds $6,099,915 across 3 Biotechnology names. GNLX ranks #1 (84.0% of the industry book) .
All Filings in GNLX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,123,582 | 2,117,183 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $8,426,619 | 1,932,711 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $7,745,215 | 1,844,099 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $5,103,680 | 1,778,286 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $3,945,005 | 1,461,113 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,993,199 | 1,268,305 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $3,183,770 | 1,343,363 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $2,438,410 | 1,250,467 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $6,982,703 | 1,085,957 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $15,162,602 | 1,082,270 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,092,425 | 44,607 | Shares | Sole | 2023-11-01 | |
| No filing history on record for this holder in this stock. | ||||||